Effects of dipeptidyl peptidase-4 inhibition in an animal model of experimental asthma: A matter of dose, route, and time

Physiological Reports

Volumn 1, Issue 5, 2013, Pages

  Stephan, Michael ^a   Suhling, Hendrik ^a   Schade, Jutta ^a   Wittlake, Mareike ^a   Tasic, Tihana ^a   Klemann, Christian ^a   Pabst, Reinhard ^a   Jurawitz, Marie Charlot ^a   Raber, Kerstin A ^b   Hoymann, Heinz G ^c   Braun, Armin ^c   Glaab, Thomas ^a   Hoffmann, Torsten ^d   Schmiedl, Andreas ^a   von Hörsten, Stephan ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c FRAUNHOFER INSTITUTE FOR TOXICOLOGY AND EXPERIMENTAL MEDICINE   (Germany)

^d PROBIODRUG AG   (Germany)

Author keywords

Airway responsiveness; Asthma; CD26; DPP4 inhibitor; Fischer 344 rats

Indexed keywords

DIPEPTIDYL PEPTIDASE IV INHIBITOR; IMMUNOGLOBULIN E; ISOLEUCINE THIAZOLIDIDE; OVALBUMIN;

ALLERGIC AIRWAY INFLAMMATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHOALVEOLAR LAVAGE FLUID; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; EXPERIMENTAL ASTHMA; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNOHISTOLOGY; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; LUNG RESISTANCE; MALE; MAXIMAL MID EXPIRATORY FLOW; NONHUMAN; PLETHYSMOGRAPHY; POLYMERASE CHAIN REACTION; RAT; SENSITIZATION;

EID: 85009067750     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.1002/phy2.95     Document Type: Article

References (31)

1. Cordero, O. J., C. P. Yang, and E. B. Bell. 2007. On the role of CD26 in CD4 memory T cells. Immunobiology 212: 85–94.
2. De Meester, I., S. Korom, J. Van Damme, and S. Scharpe. 1999. CD26, let it cut or cut it down. Immunol. Today 20: 367–375.
3. Erpenbeck, V. J., M. Ziegert, D. Cavalet-Blanco, C. Martin, R. Baelder, T. Glaab, et al. 2006. Surfactant protein D inhibits early airway response in Aspergillus fumigatus-sensitized mice. Clin. Exp. Allergy 36: 930–940.
4. Forssmann, U., C. Stoetzer, M. Stephan, C. Kruschinski, T. Skripuletz, J. Schade, et al. 2008. Inhibition of CD26/ dipeptidyl peptidase IV enhances CCL11/eotaxin-mediated recruitment of eosinophils in vivo. J. Immunol. 181: 1120–1127.
5. Gautier, J. F., S. Fetita, E. Sobngwi, and C. Salaun-Martin. 2005. Biological actions of the incretins GIP and GLP-1 and therapeutic perspectives in patients with type 2 diabetes. Diabetes Metab. 31: 233–242.
6. Glaab, T., H. G. Hoymann, J. M. Hohlfeld, R. Korolewitz, M. Hecht, Y. Alarie, et al. 2002. Noninvasive measurement of midexpiratory flow indicates bronchoconstriction in allergic rats. J. Appl. Physiol. 93: 1208–1214.
7. Hallman, M. 2004. Lung surfactant, respiratory failure, and genes. N. Engl. J. Med. 350: 1278–1280.
8. Hohlfeld, J. M. 2002. The role of surfactant in asthma. Respir. Res. 3: 4.
9. Hopsu-Havu, V. K., and G. G. Glenner. 1966. A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-beta-naphthylamide. Histochemie 7: 197–201.
10. Hoymann, H. G. 2007. Invasive and noninvasive lung function measurements in rodents. J. Pharmacol. Toxicol. Methods 55: 16–26.
11. Hoymann, H. G. 2012. Lung function measurements in rodents in safety pharmacology studies. Front. Pharmacol. 3: 156.
12. Jackson, E. K., J. H. Dubinion, and Z. Mi. 2008. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure. Clin. Exp. Pharmacol. Physiol. 35: 29–34.
13. Karl, T., W. T. Chwalisz, D. Wedekind, H. J. Hedrich, T. Hoffmann, R. Jacobs, et al. 2003. Localization, transmission, spontaneous mutations, and variation of function of the Dpp 4 (Dipeptidyl-peptidase IV; CD26) gene in rats. Regul. Pept. 115: 81–90.
14. Klemann, C., J. Schade, R. Pabst, S. Leitner, J. Stiller, S. von Horsten, et al. 2009. CD26/dipeptidyl peptidase 4-deficiency alters thymic emigration patterns and leukcocyte subsets in F344-rats age-dependently. Clin. Exp. Immunol. 155: 357–365.
15. Kruschinski, C., T. Skripuletz, S. Bedoui, T. Tschernig, R. Pabst, C. Nassenstein, et al. 2005. CD26 (dipeptidyl-peptidase IV)-dependent recruitment of T cells in a rat asthma model. Clin. Exp. Immunol. 139: 17–24.
16. Mallory, G. B. Jr. 2001. Surfactant proteins: role in lung physiology and disease in early life. Paediatr. Respir. Rev. 2: 151–158.
17. Mentlein, R. 2005. Therapeutic assessment of glucagon-like peptide-1 agonists compared with dipeptidyl peptidase IV inhibitors as potential antidiabetic drugs. Expert Opin. Investig. Drugs 14: 57–64.
18. Morimoto, C., and S. F. Schlossman. 1998. The structure and function of CD26 in the T-cell immune response. Immunol. Rev. 161: 55–70.
19. Nathan, D. M. 2007. Finding new treatments for diabetes–how many, how fast.. how good? N. Engl. J. Med. 356: 437–440.
20. Ohnuma, K., T. Yamochi, M. Uchiyama, K. Nishibashi, N. Yoshikawa, N. Shimizu, et al. 2004. CD26 up-regulates expression of CD86 on antigen-presenting cells by means of caveolin-1. Proc. Natl. Acad. Sci. USA 101: 14186–14191.
21. Ohnuma, K., T. Yamochi, O. Hosono, and C. Morimoto. 2005. CD26 T cells in the pathogenesis of asthma. Clin. Exp. Immunol. 139: 13–16.
22. Ohnuma, K., M. Uchiyama, T. Yamochi, K. Nishibashi, O. Hosono, N. Takahashi, et al. 2007. Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1. J. Biol. Chem. 282: 10117–10131.
23. Pabst, R., A. Luhrmann, I. Steinmetz, and T. Tschernig. 2003. A single intratracheal dose of the growth factor Fms-like tyrosine kinase receptor-3 ligand induces a rapid differential increase of dendritic cells and lymphocyte subsets in lung tissue and bronchoalveolar lavage, resulting in an increased local antibody production. J. Immunol. 171: 325–330.
24. Pederson, R. A., H. A. White, D. Schlenzig, R. P. Pauly, C. H. McIntosh, and H. U. Demuth. 1998. Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide. Diabetes 47: 1253–1258.
25. Rehbinder, C., S. Alenius, J. Bures, M. L. delas Heras, C. Greko, and P. S. Kroon, et al. 2000. FELASA recommendations for the health monitoring of experimental units of calves, sheep and goats Report of the federation of European Laboratory Animal Science Associations (FELASA) Working Group on Animal Health. Lab. Anim.. 34: 329–50.
26. Schade, J., M. Stephan, A. Schmiedl, L. Wagner, A. J. Niestroj, H. U. Demuth, et al. 2008. Regulation of Expression and Function of Dipeptidyl Peptidase 4 (DP4), DP8/9, and DP10 in Allergic Responses of the Lung in Rats. J. Histochem. Cytochem. 56: 147–155.
27. Schade, J., A. Schmiedl, A. Kehlen, T. Z. Veres, M. Stephan, R. Pabst, et al. 2009. Airway-specific recruitment of T cells is reduced in a CD26-deficient F344 rat substrain. Clin. Exp. Immunol. 158: 133–142.
28. Schmiedl, A., J. Krainski, F. Schwichtenhovel, J. Schade, C. Klemann, K. A. Raber, et al. 2010. Reduced airway inflammation in CD26/DPP4-deficient F344 rats is associated with altered recruitment patterns of regulatory T cells and expression of pulmonary surfactant proteins. Clin. Exp. Allergy 40: 1794–1808.
29. Skripuletz, T., A. Schmiedl, J. Schade, S. Bedoui, T. Glaab, R. Pabst, et al. 2007. Dose dependent recruitment of CD25+ and CD26+ T cells in a novel F344 rat model of asthma. Am. J. Physiol. Lung Cell. Mol. Physiol. 292: L1564–L1571.
30. Takeda, K., N. Miyahara, Y. H. Rha, C. Taube, E. S. Yang, A. Joetham, et al. 2003. Surfactant protein D regulates airway function and allergic inflammation through modulation of macrophage function. Am. J. Respir. Crit. Care Med. 168: 783–789.
31. van der Velden, V. H., and A. R. Hulsmann. 1999. Peptidases: structure, function and modulation of peptide-mediated effects in the human lung. Clin. Exp. Allergy 29: 445–456.